Post-translational modification-derived products are associated with frailty status in elderly subjects

Autor: Jean-Luc Novella, Rachid Mahmoudi, Yacine Jaidi, Sarah Badr, Stéphane Jaisson, Philippe Gillery, Laurie-Anne Bertholon
Přispěvatelé: Hôpital de Reims - Service de neuro-gériatrie, Hôpital de Reims, Matrice extracellulaire et dynamique cellulaire - UMR 7369 (MEDyC), SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Centre National de la Recherche Scientifique (CNRS), Fluides, automatique, systèmes thermiques (FAST), Université Paris-Sud - Paris 11 (UP11)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Reims (CHU Reims), Université de Reims Champagne-Ardenne (URCA)
Rok vydání: 2019
Předmět:
Glycation End Products
Advanced

Male
0301 basic medicine
Albumin concentrations
medicine.medical_specialty
Multivariate analysis
Frail Elderly
Clinical Biochemistry
Thyrotropin
Renal function
030204 cardiovascular system & hematology
Logistic regression
Hemoglobins
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Albumins
Internal medicine
medicine
Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

Frail elderly
Pentosidine
ComputingMilieux_MISCELLANEOUS
Aged
Aged
80 and over

Homocitrulline
business.industry
Biochemistry (medical)
General Medicine
3. Good health
C-Reactive Protein
030104 developmental biology
chemistry
Creatinine
Posttranslational modification
Female
business
Protein Processing
Post-Translational

Blood Chemical Analysis
Glomerular Filtration Rate
Zdroj: Clinical Chemistry and Laboratory Medicine
Clinical Chemistry and Laboratory Medicine, De Gruyter, 2019, 57 (8), pp.1153-1161. ⟨10.1515/cclm-2018-1322⟩
ISSN: 1437-4331
1434-6621
DOI: 10.1515/cclm-2018-1322
Popis: Background Identifying frail elderly subjects is of paramount importance in order to conduct a tailored care. The characterization of frailty status is currently based on the collection of clinical data and on the use of various tools such as Fried’s criteria, which constitutes a difficult and time-consuming process. Up to now, no biological markers have been described as reliable tools for frailty characterization. We tested the hypothesis that a link between frailty and protein molecular aging existed. This study aimed therefore at determining whether post-translational modification derived products (PTMDPs), recognized as biomarkers of protein aging, were associated with frailty status in elderly subjects. Methods Frailty status was determined according to Fried’s criteria in 250 elderly patients (>65 years old) hospitalized in a short-term care unit. Serum concentrations of protein-bound PTMDPs, including carboxymethyllysine (CML), pentosidine, methylglyoxal-hydroimidazolone-1 and homocitrulline (HCit), were determined by liquid chromatography coupled with tandem mass spectrometry, and tissue content of advanced glycation end-products was assessed by skin autofluorescence (SAF) measurement. Associations between PTMDPs and frailty status were analyzed using logistic regression models. Results Frail patients had significantly (p Conclusions HCit and SAF are significantly associated with frailty status in elderly subjects. This study suggests that PTMDPs constitute promising biomarkers for identifying frail patients and guiding personalized patient care.
Databáze: OpenAIRE